This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5jm5
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of AKR1C3 complexed with a pro-drug== | |
| - | + | <StructureSection load='5jm5' size='340' side='right' caption='[[5jm5]], [[Resolution|resolution]] 1.99Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5jm5]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5JM5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5JM5 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6LG:(1R)-1-{3-[3-(DIMETHYLCARBAMOYL)PHENOXY]-4-NITROPHENYL}ETHYL+BIS[(AZIRIDIN-1-YL)]PHOSPHINATE'>6LG</scene>, <scene name='pdbligand=6NY:3-{2-(HYDROXYAMINO)-5-[(1S)-1-HYDROXYETHYL]PHENOXY}-N,N-DIMETHYLBENZAMIDE'>6NY</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene></td></tr> | |
| - | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5jm5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5jm5 OCA], [http://pdbe.org/5jm5 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5jm5 RCSB], [http://www.ebi.ac.uk/pdbsum/5jm5 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5jm5 ProSAT]</span></td></tr> |
| - | [[Category: | + | </table> |
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/AK1C3_HUMAN AK1C3_HUMAN]] Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone. | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Li, Q]] | ||
[[Category: Wang, C]] | [[Category: Wang, C]] | ||
| - | [[Category: Li, Q]] | ||
[[Category: Wang, Z]] | [[Category: Wang, Z]] | ||
| + | [[Category: Xie, W]] | ||
| + | [[Category: Akr1c3]] | ||
| + | [[Category: Inhibitor]] | ||
| + | [[Category: Liver cancer]] | ||
| + | [[Category: Oxidoreductase-oxidoreductase inhibitor complex]] | ||
| + | [[Category: Pro-drug]] | ||
Revision as of 13:08, 4 May 2017
Crystal structure of AKR1C3 complexed with a pro-drug
| |||||||||||
